CN101918430A - 非糖基化蛋白质的纯化 - Google Patents
非糖基化蛋白质的纯化 Download PDFInfo
- Publication number
- CN101918430A CN101918430A CN2009801023313A CN200980102331A CN101918430A CN 101918430 A CN101918430 A CN 101918430A CN 2009801023313 A CN2009801023313 A CN 2009801023313A CN 200980102331 A CN200980102331 A CN 200980102331A CN 101918430 A CN101918430 A CN 101918430A
- Authority
- CN
- China
- Prior art keywords
- chromatography
- polypeptide
- carried out
- exchange chromatography
- hydrophobic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710044891.4A CN107033233A (zh) | 2008-01-18 | 2009-01-15 | 非糖基化蛋白质的纯化 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08000884.0 | 2008-01-18 | ||
| EP08000884 | 2008-01-18 | ||
| PCT/EP2009/000192 WO2009090056A2 (en) | 2008-01-18 | 2009-01-15 | Purification of not-glycosylated polypeptides |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710044891.4A Division CN107033233A (zh) | 2008-01-18 | 2009-01-15 | 非糖基化蛋白质的纯化 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101918430A true CN101918430A (zh) | 2010-12-15 |
Family
ID=39810157
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009801023313A Pending CN101918430A (zh) | 2008-01-18 | 2009-01-15 | 非糖基化蛋白质的纯化 |
| CN201710044891.4A Pending CN107033233A (zh) | 2008-01-18 | 2009-01-15 | 非糖基化蛋白质的纯化 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710044891.4A Pending CN107033233A (zh) | 2008-01-18 | 2009-01-15 | 非糖基化蛋白质的纯化 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US20110034672A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2245044A2 (cg-RX-API-DMAC7.html) |
| JP (2) | JP5944101B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20100103595A (cg-RX-API-DMAC7.html) |
| CN (2) | CN101918430A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2009204998B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2711375C (cg-RX-API-DMAC7.html) |
| IL (1) | IL206158A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2009090056A2 (cg-RX-API-DMAC7.html) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102219848A (zh) * | 2011-05-25 | 2011-10-19 | 浙江海正药业股份有限公司 | 重组人干扰素β-1a的纯化方法 |
| CN104710527B (zh) * | 2015-02-28 | 2018-08-24 | 苏州金盟生物技术有限公司 | 一种生物制品的内毒素去除方法 |
| CN114341634A (zh) * | 2019-09-25 | 2022-04-12 | 豪夫迈·罗氏有限公司 | 利用预测的洗脱缓冲液盐浓度的阳离子色谱 |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101918430A (zh) * | 2008-01-18 | 2010-12-15 | 弗·哈夫曼-拉罗切有限公司 | 非糖基化蛋白质的纯化 |
| DE102009032179A1 (de) * | 2009-07-07 | 2011-01-13 | Biogenerix Ag | Verfahren zur Reinigung von Interferon beta |
| US20140154233A1 (en) | 2012-12-05 | 2014-06-05 | Csl Limited | Method of purifying therapeutic proteins |
| US10188965B2 (en) | 2012-12-05 | 2019-01-29 | Csl Behring Gmbh | Hydrophobic charge induction chromatographic depletion of a protein from a solution |
| HUE049756T2 (hu) * | 2015-11-09 | 2020-10-28 | Biological E Ltd | Ipari méretekben is alkalmazható eljárás biológiailag aktív, rekombináns hordozófehérjék kinyerésére |
| KR20220145361A (ko) * | 2020-02-24 | 2022-10-28 | 노파르티스 아게 | 재조합적으로 생성된 폴리펩타이드의 정제 |
| KR20230125179A (ko) * | 2020-12-23 | 2023-08-29 | 재즈 파마슈티칼즈 아일랜드 리미티드 | 전하-차폐 융합 단백질의 정제 방법 |
| CN113480632B (zh) * | 2021-07-30 | 2023-02-03 | 宁波人健药业集团股份有限公司 | 一种在CHO细胞中表达的重组蛋白rhCG纯化工艺 |
| TW202403043A (zh) * | 2022-03-18 | 2024-01-16 | 美商健臻公司 | 重組人類酸性鞘磷脂酶醫藥組合物及方法 |
| CN117024561B (zh) * | 2023-10-10 | 2024-02-20 | 哈药集团生物工程有限公司 | 一种聚乙二醇修饰干扰素的纯化方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH651308A5 (de) * | 1980-07-01 | 1985-09-13 | Hoffmann La Roche | Interferone und deren herstellung. |
| US5696238A (en) * | 1991-08-20 | 1997-12-09 | Chiron Corporation | Purified GP120 composition retaining natural conformation |
| DE4329756A1 (de) * | 1993-09-03 | 1995-03-09 | Boehringer Ingelheim Int | Verfahren zur Herstellung und Reinigung von alpha-Interferon |
| EP0626448A3 (de) * | 1993-05-26 | 1998-01-14 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Verfahren zur Herstellung und Reinigung von alpha-Interferon |
| EP1104809A1 (en) * | 1994-04-09 | 2001-06-06 | F. Hoffmann-La Roche Ag | Process for producing alpha-interferon |
| TW517067B (en) * | 1996-05-31 | 2003-01-11 | Hoffmann La Roche | Interferon conjugates |
| KR100443890B1 (ko) | 2001-04-11 | 2004-08-09 | 한미약품 주식회사 | 재조합 대장균으로부터 인간 성장 호르몬의 정제 방법 |
| CN1233816C (zh) * | 2002-04-16 | 2005-12-28 | 海南海梁生物高科技有限公司 | 酵母重组株及IFNα-la干扰素的纯化方法 |
| SI1501369T1 (sl) * | 2002-04-26 | 2015-10-30 | Genentech, Inc. | Neafinitetno čiščenje proteinov |
| SI1656455T1 (sl) * | 2003-08-13 | 2012-12-31 | Sandoz Ag | Postopek za čiščenje rekombinantnih polipeptidov |
| ES2285543T3 (es) | 2003-11-05 | 2007-11-16 | Ares Trading S.A. | Procedimiento para la purificacion de la proteina de union a il-18. |
| ATE446314T1 (de) | 2003-12-22 | 2009-11-15 | Ares Trading Sa | Methode zur reinigung von fsh |
| SE0400886D0 (sv) * | 2004-04-02 | 2004-04-02 | Amersham Biosciences Ab | Process of purification |
| WO2005113592A2 (en) * | 2004-05-19 | 2005-12-01 | Maxygen, Inc. | Interferon-alpha polypeptides and conjugates |
| CA2602947A1 (en) | 2005-03-24 | 2006-09-28 | Straumann Holding Ag | Method for protein purification comprising heat incubation in acetic acidic solution |
| WO2007016250A1 (en) | 2005-07-28 | 2007-02-08 | Genvec, Inc. | Method of purifying protein |
| CN1916024A (zh) * | 2005-08-17 | 2007-02-21 | 海南国栋药物研究所有限公司 | 高比活人α-2b干扰素突变体序列、酵母表达质粒的构建及菌株筛选和纯化方法 |
| JP5364375B2 (ja) * | 2005-10-04 | 2013-12-11 | ザイモジェネティクス リミテッド ライアビリティ カンパニー | Il−29の生産および精製の方法 |
| EP1963367A4 (en) | 2005-12-06 | 2009-05-13 | Amgen Inc | POLISHING STEPS IN MULTI-STAGE PROTEIN PURIFICATION TREATMENTS |
| CN101918430A (zh) * | 2008-01-18 | 2010-12-15 | 弗·哈夫曼-拉罗切有限公司 | 非糖基化蛋白质的纯化 |
| CN103864915B (zh) * | 2012-12-07 | 2016-06-08 | 天津未名生物医药有限公司 | 纯化重组人干扰素α2b的方法和试剂盒 |
| CN104356223B (zh) * | 2014-11-26 | 2017-11-10 | 安徽安科生物工程(集团)股份有限公司 | 高纯度重组人干扰素α2b的制备方法 |
-
2009
- 2009-01-15 CN CN2009801023313A patent/CN101918430A/zh active Pending
- 2009-01-15 EP EP09702937A patent/EP2245044A2/en not_active Withdrawn
- 2009-01-15 US US12/811,397 patent/US20110034672A1/en not_active Abandoned
- 2009-01-15 JP JP2010542579A patent/JP5944101B2/ja not_active Expired - Fee Related
- 2009-01-15 CA CA2711375A patent/CA2711375C/en not_active Expired - Fee Related
- 2009-01-15 WO PCT/EP2009/000192 patent/WO2009090056A2/en not_active Ceased
- 2009-01-15 CN CN201710044891.4A patent/CN107033233A/zh active Pending
- 2009-01-15 KR KR1020107015694A patent/KR20100103595A/ko not_active Ceased
- 2009-01-15 AU AU2009204998A patent/AU2009204998B2/en not_active Ceased
-
2010
- 2010-06-03 IL IL206158A patent/IL206158A/en active IP Right Grant
-
2012
- 2012-09-21 US US13/624,091 patent/US20130190478A1/en not_active Abandoned
-
2014
- 2014-04-07 US US14/246,783 patent/US9481706B2/en not_active Expired - Fee Related
- 2014-07-03 JP JP2014137837A patent/JP2014210797A/ja active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102219848A (zh) * | 2011-05-25 | 2011-10-19 | 浙江海正药业股份有限公司 | 重组人干扰素β-1a的纯化方法 |
| CN102219848B (zh) * | 2011-05-25 | 2014-01-22 | 浙江海正药业股份有限公司 | 重组人干扰素β-1a的纯化方法 |
| CN104710527B (zh) * | 2015-02-28 | 2018-08-24 | 苏州金盟生物技术有限公司 | 一种生物制品的内毒素去除方法 |
| CN114341634A (zh) * | 2019-09-25 | 2022-04-12 | 豪夫迈·罗氏有限公司 | 利用预测的洗脱缓冲液盐浓度的阳离子色谱 |
| CN114341634B (zh) * | 2019-09-25 | 2024-01-23 | 豪夫迈·罗氏有限公司 | 利用预测的洗脱缓冲液盐浓度的阳离子色谱 |
| US12674784B2 (en) | 2019-09-25 | 2026-07-07 | Hoffmann-La Roche Inc. | Cation chromatography using predicted elution buffer salt concentration |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20100103595A (ko) | 2010-09-27 |
| AU2009204998B2 (en) | 2014-03-27 |
| US9481706B2 (en) | 2016-11-01 |
| JP2011509963A (ja) | 2011-03-31 |
| CA2711375C (en) | 2019-04-16 |
| JP5944101B2 (ja) | 2016-07-05 |
| IL206158A0 (en) | 2010-12-30 |
| US20110034672A1 (en) | 2011-02-10 |
| US20130190478A1 (en) | 2013-07-25 |
| CA2711375A1 (en) | 2009-07-23 |
| WO2009090056A3 (en) | 2010-01-21 |
| CN107033233A (zh) | 2017-08-11 |
| WO2009090056A2 (en) | 2009-07-23 |
| AU2009204998A1 (en) | 2009-07-23 |
| US20140220633A1 (en) | 2014-08-07 |
| JP2014210797A (ja) | 2014-11-13 |
| EP2245044A2 (en) | 2010-11-03 |
| IL206158A (en) | 2016-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2711375C (en) | Purification of not-glycosylated polypeptides | |
| DK3040346T3 (en) | PROCEDURE FOR CLEANING THE GRANULOCYT COLONY STIMULATING FACTOR, G-CSF | |
| CN100384874C (zh) | 用蛋白质a和离子交换层析来纯化抗体 | |
| TWI395619B (zh) | 層析方法 | |
| CN102712673B (zh) | 用于纯化含fc的蛋白的色谱方法 | |
| KR20070072510A (ko) | 항체 정제를 위한 친화도- 및 이온 교환- 크로마토그래피 | |
| CN101889023A (zh) | Peg化的多肽的纯化 | |
| US20220017570A1 (en) | Method for purifying pegylated protein | |
| KR20200104381A (ko) | 페길화 단백질 조성물의 제공 방법 | |
| CN103703015B (zh) | 阳离子和阴离子交换层析法 | |
| JP5635682B2 (ja) | 疎水性相互作用クロマトグラフィー法 | |
| US20250215050A1 (en) | Compositions and methods for purifying biological fluids | |
| Akhtar et al. | Evaluation of the efficiency of protein A affinity chromatography to purify a monoclonal antibody for cancer treatment and its purity analysis | |
| KR20200104382A (ko) | 페길화 단백질 조성물의 제공 방법 | |
| HK1193617A (en) | Cation and anion exchange chromatography method | |
| HK1181458A (en) | Hydrophobic interaction chromatography method | |
| HK40038492A (en) | Process for providing pegylated protein composition | |
| HK1193617B (en) | Cation and anion exchange chromatography method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20101215 |